Bizarre Patents
Cloaking System Using Optoelectronically Controlled Camouflage
A Cloaking System designed to operate in the visible light spectrum, utilizes optoelectronics and/or photonic components to conceal an object within it.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8163799 | Amido-amine polymer compositions Compounds, polymers, crosslinked polymers and pharmaceutical compositions comprising the same may be derived from multi-amine monomers and multi-functional monomers having two or more amine reactive groups. Such compounds, polymers, crosslinked polymers and composit... | 04/24/2012 |
| 8119690 | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof There are provided various polyunsaturated fatty acid monoglycerides and derivatives thereof. These compounds can be useful as cancer chemopreventive agents, cancer treating agent, inhibiting tumor growth or cell proliferation, reducing tumor growth or as radioenhen... | 02/21/2012 |
| 8114906 | Essential fatty acids in the treatment and/or inhibition of depression in patients with coronary heart or artery disease A method of treating or inhibiting depression in a patient with cardiovascular disease, especially a patient suffering from coronary artery or vascular disease, the method including administering, preferably orally, to the patient a therapeutically effective amount ... | 02/14/2012 |
| 8110602 | Compounds comprising heterocyclic-substituted piperidine for treating pain The invention relates to Heterocyclic-Substituted Piperidine Compounds, compositions comprising an effective amount of a Heterocyclic-Substituted Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administering to an animal in ... | 02/07/2012 |
| 7935729 | Use of triglyceride oils containing γ-linolenic acid residues and linoleic acid residues for the treatment of neurodegenerative disease Method for treating a patient in need of therapy for a neurodegenerative disease by administering to that patient a therapeutically effective dose of a triglyceride oil containing both γ-linolenic acid and linolenic acid residues as triglyceride ester. The ratio of... | 05/03/2011 |
| 7902257 | Trihydroxy polyunsaturated eicosanoid The invention features methods for the preparation of naturally occurring trihydroxy polyunsaturated eicosanoids and their structural analogs. The invention further provides new derivatives and analogs of trihydroxy polyunsaturated eicosanoids that can be prepared a... | 03/08/2011 |
| 7902256 | Pest treatment composition The present invention provides a pediculicidal and ovicidal composition with an extraordinarily lethal effectiveness that can also be used to remove parasites, such as lice. The pediculicidal and ovicidal composition contains a purified terpene agent such as citrone... | 03/08/2011 |
| 7893106 | Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same Disclosed are novel oxylipins that are derived from γ-linolenic acid (GLA; 18:3n-6) and stearidonic acid (STA or SDA; 18:4n-3), and methods of making and using such oxylipins. Also disclosed is the use of such oxylipins in therapeutic and nutritional or cosmetic ap... | 02/22/2011 |
| 7884131 | Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same Disclosed are novel oxylipins, referred to herein as docosanoids, that are derived from C22 polyunsaturated fatty acids, and method of making and using such oxylipins. Also disclosed is the use of docosapentaenoic acid (C22:5n-6) (DPAn-6), docosapentaenoic acid (C22... | 02/08/2011 |
| 7872047 | Esters of long-chain alcohols and preparation thereof Disclosed is a composition and methods of treating a skin condition. The ester includes an ester and a dermatologically acceptable carrier. The ester is represented by the general formula 1: ... | 01/18/2011 |
| 7812054 | Lipoxin analogs and methods for the treatment of periodontal disease This invention provides new lipoxin analogs, compositions containing analogs, and methods of using these compounds and compositions for treating and preventing oral inflammation, including gingivitis, periodontitis, and other forms of periodontal disease. The invent... | 10/12/2010 |
| 7772279 | Use of vegetable butter-based cetyl myristoleate for treating osteoarthritis and other musculoskeletal disease conditions and injuries A vegetable butter based dietary supplement of cetyl myristoleate is disclosed for use in the treatment of osteoarthritis and other joint inflammatory diseases of the musculoskeletal system in animals, especially equines. In its preferred form, the cetyl myristoleat... | 08/10/2010 |
| 7700650 | Lipoxin analogs and method for the treatment of periodontal disease This invention provides new lipoxin analogs, compositions containing these analogs, and methods of using these compounds and compositions for treating and preventing oral inflammation, including gingivitis, periodontitis, and other forms of periodontal disease. The ... | 04/20/2010 |
| 7619002 | Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events The use of polyunsaturated fatty acids of the ω-3 series such as eicosapentaenoic acid (EPA, C.sub.20:5 ω-3), docosahexaenoic acid (DHA, C.sub.22:6 ω-3), or their pharmaceutically acceptable derivatives is described for the primary prevention of major cardiovascu... | 11/17/2009 |
| 7615576 | Prevention of neutrophil recruitment Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II. ... | 11/10/2009 |
| 7595341 | Analogues of lipid mediators derived from ω-3 PUFAs and methods of use The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ω-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to trea... | 09/29/2009 |
| 7553870 | Use of polyunsaturated fatty acid for the primary prevention of major cardiovascular events The use of polyunsaturated fatty acids of the ω-3 series such as eicosapentaenoic acid (EPA, C20:5 ω-3), docosahexaenoic acid (DHA, C22:6 ω-3), or their pharmaceutically acceptable derivatives is described for the primary prevention of major... | 06/30/2009 |
| 7462643 | Essential fatty acids in the prevention of cardiovascular events The invention concerns the use of essential fatty acids with a high content in eicosapentaenoic acid ethyl ester (EPA) or docosahexaenoic acid ethyl ester (DHA) or a high concentration mixture thereof in the preparation of a medicament useful for preventing mortalit... | 12/09/2008 |
| 7439267 | Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy The present invention concerns a method of therapeutic prevention and treatment of a heart disease chosen from cardiac insufficiency and heart failure including the administration of an essential fatty acid containing a mixture of eicosapentaenoic acid ethyl ester (... | 10/21/2008 |
| 7414075 | Composition for lowering internal lipid content A composition for lowering internal lipid in a subject which contains a capsinoid substance represented by the following formula wherein n is an integer from 0 to 10. Methods of using the compositions are disclosed and incl... | 08/19/2008 |
| 7381416 | Selenohydroxy acids and their derivatives, applications in nutrition, cosmetics and pharmaceutics The purpose of this invention is: new selenohydroxy acid compounds and their derivatives; their process for the preparation; use of the new compounds as precursors of L(+)-selenomethionine and/or s... | 06/03/2008 |
| 7378445 | Treatment of prostate cancer A chemical agent of the diterpene family obtained from a member of the Euphorbiaceae family of plants for use in the treatment of prophylaxis of prostate cancer or a related cancer or condition. ... | 05/27/2008 |
| 7378443 | Fatty acid analogues for the treatment of cancer A fatty acid analogue of the general formula: R1-[xi-CH2]n—COOR2, wherein R1 is: a C2-C24 alkene with one or more double bonds and/or with one or more triple bonds, and/or a C | 05/27/2008 |
| 7378444 | Analogues of lipid mediators derived from omega-3 PUFAs and methods of use The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ω-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to trea... | 05/27/2008 |
| 7368435 | Topical endoparasiticide and ectoparasiticide formulations A topical formulation having significant parasiticidal activity effective against endoparasites and/or ectoparasites such as heartworms, mites, fleas, ticks, flies is provided, which can be safe to use and avoids the many common deleterious side effects of conventio... | 05/06/2008 |
| 7361664 | Vitamin D receptor antagonists and related compositions and methods of use A compound of formula: wherein X is a C2-10 spacer, and R is a substituted or unsubstituted C6-30 aryl, a substituted or unsubstituted C5-30 heteroaryl, or ... | 04/22/2008 |
| 7348019 | Stabilized block pesticide compositions The present invention provides a solid block formulation, and methods of making and methods of use. In addition, methods of controlling insects on cattle are also provided. ... | 03/25/2008 |
| 7345092 | High concentration topical insecticides containing pyrethroids A topical insecticide preparation is provided which can be safe to use and avoids many common deleterious side effects of conventional topical insecticides. The topical insecticide contains a combination of a first pyrethroid insecticide effective for killing fleas,... | 03/18/2008 |
| 7338681 | Process to prepare a premium formulated fried egg The present invention relates to the formulation and process for preparation of a fried egg product which may be frozen for future heating within a microwave or other oven for consumption by an individual. Various ingredients are added and mixed to each of the liqui... | 03/04/2008 |
| 7323206 | Reagents and methods for all-in-one total parenteral nutrition for neonates and infants Materials and methods for preparing and using All-in-One (“AIO”) formulations suitable for administration to infants and neonates for total parenteral nutrition are provided. ... | 01/29/2008 |
| 7323553 | Non-affinity purification of proteins The present invention relates to a method for protein purification that involves the combination of non-affinity chromatography with HPTFF. ... | 01/29/2008 |
| 7323476 | Myriceric acid derivatives for the treatment of cancer, cardiovascular and inflammatory diseases The present invention relates to the use of certain novel myriceric acid derivatives of the formula: which are inhibitors of nuclear factor kappa B (NF-κB) and inhibit the activity of the endothelin receptor for... | 01/29/2008 |
| 7320999 | Dimethyl fumarate for the treatment of multiple sclerosis The present invention relates to the use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets. For ... | 01/22/2008 |
| 7314624 | Nanoemulsion vaccines The present invention provides methods and compositions for the stimulation of immune responses. Specifically, the present invention provides methods and compositions for the use of nanoemulsion compounds as mucosal adjuvants to induce immunity against environmental... | 01/01/2008 |
| 7304089 | Preparation for improved dietary utilisation Food, feed or drug preparations are described that contain conjugated trans/cis-octadecatrienoic acid, and processes are described for their production. Inventive preparations preferably comprise calendic acid. The invention also relates to the use of the preparatio... | 12/04/2007 |
| 7288279 | Formulated fried egg product The present invention relates to the formulation and process for preparation of a fried egg product which may be frozen for future heating within a microwave or other oven for consumption by an individual. Various ingredients are added and mixed to each of the liqui... | 10/30/2007 |
| 7282211 | Pest treatment composition The present invention provides a pediculicidal and ovicidal composition with an extraordinarily lethal effectiveness that can also be used to remove parasites, such as lice. The pediculicidal and ovicidal composition contains a purified terpene agent such as citrone... | 10/16/2007 |
| 7265155 | Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound Preparations and extracts of valerian, as well as isovaleramide, isovaleric acid, and certain structurally related compounds, exhibit clinically significant pharmacological properties that implicate a treatment for a variety of pathological conditions, including spa... | 09/04/2007 |
| 7261880 | Methods of treating Syndrome X with aliphatic polyamines The invention relates to a method for treating Syndrome X, or inhibiting the onset of symptoms of Syndrome X in a patient, and includes administering a therapeutically effective amount of a salt of at least one alkylated and cross-linked polymer, or a copolymer ther... | 08/28/2007 |
| 7241469 | Formulation and process to prepare a pre-formed filing unit The present process relates to a formulation for a food product and preparation of a pre-formed filling unit for the provision of a consumable food product containing eggs, which may be refrigerated and/or frozen for future heating within a microwave oven for consum... | 07/10/2007 |
